FDA Closed-Door Hemopure Meeting Violates Advisory Committee Act, Cries Wolfe
This article was originally published in The Pink Sheet Daily
Executive Summary
Public Citizen is seeking a temporary restraining order against FDA’s Blood Products Advisory Committee closed-door review of Biopure’s oxygen therapeutic.